Jérôme J J Schuch1, Annelieke M Roest2, Willem A Nolen2, Brenda W J H Penninx3, Peter de Jonge2. 1. Department of Psychiatry and Interdisciplinary Center Psychopathology and Emotion Regulation, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. Electronic address: h.j.j.schuch@umcg.nl. 2. Department of Psychiatry and Interdisciplinary Center Psychopathology and Emotion Regulation, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. 3. Department of Psychiatry and Interdisciplinary Center Psychopathology and Emotion Regulation, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands; Department of Psychiatry/EMGO Institute/Neuroscience, Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands; Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands.
Abstract
BACKGROUND: Although an overall gender difference in prevalence of major depressive disorder (MDD) has been well established, several questions concerning gender differences in the clinical manifestation of depression remain. This study aims to identify gender differences in psychopathology, treatment, and public health consequences in patients with MDD. METHODS: Baseline data from the Netherlands Study of Depression and Anxiety (NESDA) were used, including 1115 participants (364 men, 751 women, mean age 41 years) with a DSM-IV diagnosis of current MDD. Characteristics studied included symptom profiles, comorbidity, treatment, and public health consequences. RESULTS: Women reported a younger age of onset of single (27.8 years vs. 31.6 years; p=0.001) and recurrent MDD (24.8 years vs. 27.6 years; p=0.014), a higher comorbidity of panic disorder with agoraphobia (24.9% vs. 17.3%; p=0.006) and life-time overall anxiety disorder (77.6% vs. 71.4%; p=0.029) than men. More men than women suffered from comorbid alcohol dependence or abuse (48.1% vs. 24.5%; p<0.001). An increased prevalence of atypical depression in women (24.6% vs. 17.3%; p=0.009) was found. Women were treated more frequently by an alternative caretaker (20.6% vs. 14.8%; p=0.025), men more often in mental health care organizations (61.0% vs. 53.7%; p=0.025). No gender differences in frequency of medication use or counseling were found. LIMITATIONS: Cross sectional design. CONCLUSIONS: Main gender differences in the clinical presentation of MDD concerned a younger age of onset, higher anxiety and lower alcohol use comorbidity and higher prevalence of atypical depression in women. These differences were accompanied by differences in health care use.
BACKGROUND: Although an overall gender difference in prevalence of major depressive disorder (MDD) has been well established, several questions concerning gender differences in the clinical manifestation of depression remain. This study aims to identify gender differences in psychopathology, treatment, and public health consequences in patients with MDD. METHODS: Baseline data from the Netherlands Study of Depression and Anxiety (NESDA) were used, including 1115 participants (364 men, 751 women, mean age 41 years) with a DSM-IV diagnosis of current MDD. Characteristics studied included symptom profiles, comorbidity, treatment, and public health consequences. RESULTS:Women reported a younger age of onset of single (27.8 years vs. 31.6 years; p=0.001) and recurrent MDD (24.8 years vs. 27.6 years; p=0.014), a higher comorbidity of panic disorder with agoraphobia (24.9% vs. 17.3%; p=0.006) and life-time overall anxiety disorder (77.6% vs. 71.4%; p=0.029) than men. More men than women suffered from comorbid alcohol dependence or abuse (48.1% vs. 24.5%; p<0.001). An increased prevalence of atypical depression in women (24.6% vs. 17.3%; p=0.009) was found. Women were treated more frequently by an alternative caretaker (20.6% vs. 14.8%; p=0.025), men more often in mental health care organizations (61.0% vs. 53.7%; p=0.025). No gender differences in frequency of medication use or counseling were found. LIMITATIONS: Cross sectional design. CONCLUSIONS: Main gender differences in the clinical presentation of MDD concerned a younger age of onset, higher anxiety and lower alcohol use comorbidity and higher prevalence of atypical depression in women. These differences were accompanied by differences in health care use.
Authors: Bradley T Kerridge; Tulshi D Saha; S Patricia Chou; Haitao Zhang; Jeesun Jung; W June Ruan; Sharon M Smith; Boji Huang; Deborah S Hasin Journal: Drug Alcohol Depend Date: 2015-09-02 Impact factor: 4.492
Authors: Nwakile Ojike; James R Sowers; Azizi Seixas; Joseph Ravenell; G Rodriguez-Figueroa; M Awadallah; F Zizi; Girardin Jean-Louis; Olugbenga Ogedegbe; Samy I McFarlane Journal: Cardiorenal Med Date: 2016-02-25 Impact factor: 2.041
Authors: Joseph T F Lau; Yoona Kim; Anise M S Wu; Zixin Wang; Bishan Huang; Phoenix K H Mo Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2017-03-03 Impact factor: 4.328
Authors: Rebecca B Price; Kathleen Gates; Thomas E Kraynak; Michael E Thase; Greg J Siegle Journal: Neuropsychopharmacology Date: 2017-05-12 Impact factor: 7.853
Authors: Lisa Townsend; Rashelle Musci; Elizabeth Stuart; Kathryn Heley; Mary Beth Beaudry; Barbara Schweizer; Anne Ruble; Karen Swartz; Holly Wilcox Journal: J Adolesc Health Date: 2019-01-04 Impact factor: 5.012
Authors: Maciej Trzaskowski; Divya Mehta; Wouter J Peyrot; David Hawkes; Daniel Davies; David M Howard; Kathryn E Kemper; Julia Sidorenko; Robert Maier; Stephan Ripke; Manuel Mattheisen; Bernhard T Baune; Hans J Grabe; Andrew C Heath; Lisa Jones; Ian Jones; Pamela A F Madden; Andrew M McIntosh; Gerome Breen; Cathryn M Lewis; Anders D Børglum; Patrick F Sullivan; Nicholas G Martin; Kenneth S Kendler; Douglas F Levinson; Naomi R Wray Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2019-02-01 Impact factor: 3.568